RZLT · Rezolute, Inc.
$5.09
+0.64 (+14.38%)
At close · Jul 21
Market Cap
$490.13M
Shares
96.29M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$74.4M
-8.7%
FY2025
Diluted EPS
-$0.98
+26.3%
FY2025
Operating Cash Flow
-$69.1M
-20.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $59.77M | $61.53M | $55.74M | $43.81M | $32.49M | $14.99M | $14.45M | $19.08M | $17.28M | $12.09M | $9.45M | $4.7M | $34.32K | $3494 | $0 | |
| $27.48M | $18.37M | $14.68M | $12.18M | $9.36M | $7.91M | $6.07M | $6.87M | $9.1M | $8.23M | $5.5M | $6M | $5.14M | $28.66K | $42.67K | |
| — | — | — | — | — | — | $7000 | $7000 | $7000 | $7292 | $7292 | $5255 | $3544 | $295 | — | |
| — | $31K | $36K | $30K | $13K | $13K | $18K | $49K | $1.07M | — | — | — | $11.3K | $295 | — | |
| — | — | — | — | — | $201K | — | — | — | — | — | — | — | — | — | |
| $87.25M | $79.89M | $70.42M | $55.99M | $41.84M | $22.89M | $20.52M | $25.94M | $28.73M | $20.32M | $14.95M | $10.7M | $5.18M | $6.11M | $49.29K | |
| -$87.25M | -$79.89M | -$70.42M | -$55.99M | -$41.84M | -$22.89M | -$20.52M | -$25.94M | -$28.73M | -$20.32M | -$14.95M | -$10.7M | -$5.18M | -$6.11M | — | |
| — | — | — | — | — | $375K | $0 | $4.96M | $689K | $1595 | $5039 | $6729 | $4.23M | $568.86K | — | |
| $11.84K | — | — | — | — | — | — | — | $1000 | $0 | $965 | $4970 | $12.18K | $106.04K | — | |
| $5.77M | $5.48M | $1.96M | $4.2M | $783K | $1.99M | $188K | -$4.5M | -$1.13M | $46.92K | $15.75K | -$664.48K | -$4.55M | -$620.58K | — | |
| — | — | — | — | — | — | -$12M | — | — | — | — | — | — | — | — | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| -$81.47M | -$74.4M | -$68.46M | -$51.79M | -$41.06M | -$20.9M | -$20.33M | -$30.45M | -$29.86M | -$20.28M | -$14.94M | -$11.36M | -$9.73M | -$6.73M | -$783.38K | |
| — | — | — | — | — | — | — | $2.27M | $0 | — | — | — | — | — | — | |
| — | -$74.41M | -$68.46M | -$51.79M | -$41.06M | -$20.9M | -$20.33M | -$32.72M | -$29.86M | -$23.68M | -$20.91M | -$11.36M | — | — | — | |
| -$81.64M | -$74.34M | -$68.19M | -$52.14M | -$41.06M | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | -$0.98 | -$1.33 | -$1.01 | -$2.26 | -$2.72 | — | — | — | — | — | — | -$52.00 | -$54.00 | — |
| USD/shares | — | -$0.98 | -$1.33 | -$1.01 | -$2.32 | -$2.72 | — | — | — | — | — | — | -$52.00 | -$54.00 | — |
| shares | — | 76M | 51.47M | 51.19M | 18.2M | 7.67M | 5751 | 1777 | 1113.1 | 825.93K | 495.46K | 419K | 187.69K | 124.09K | — |
| shares | — | 76M | 51.47M | 51.19M | 19.49M | 7.67M | 5751 | 1777 | 1113.1 | 825.93K | 495.46K | 419K | 187.69K | 124.09K | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.46×
EV/EBIT
—
Biotechnology median 26.45×
P/E (TTM)
—
Biotechnology median 7.03×
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| Single Reportable Segment | -$79,894,000 | -$70,423,000 |